Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$16.29
+5.91%
Mkt Cap $1.90B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
Implied Upside
+18.2%
Consensus $19.25 vs current $16.29
NASDAQ·Healthcare·Biotechnology
$16.29
+5.91%
Mkt Cap $1.90B
Buy
13
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
+18.2%
Consensus $19.25 vs current $16.29